| Literature DB >> 36087084 |
Abstract
During the past 50 years, there has been a remarkable transformation in the management of lung and esophageal cancers. Improved methods of diagnosis, better staging and patient selection for surgery, the advent of minimally invasive approaches to resection, decreasing operative mortality, greater insights into tumor biology, and the development of effective multimodality therapies and precision medicine have contributed to this transformation. Progress has been most notable in lung cancer.Entities:
Keywords: esophageal cancer; lung cancer; treatment advances
Mesh:
Year: 2022 PMID: 36087084 PMCID: PMC9472872 DOI: 10.1002/jso.27033
Source DB: PubMed Journal: J Surg Oncol ISSN: 0022-4790 Impact factor: 2.885